Local inflammatory response around diffusion chambers containing xenografts: Nonspecific destruction of tissues and decreased local vascularization

Transplantation

Volumn 61, Issue 12, 1996, Pages 1671-1677

  Brauker, James ^a   Martinson, Laura A ^a   Young, Susan K ^a   Johnson, Robert C ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLITEF;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIFFUSION CHAMBER; IMMUNITY; INFLAMMATION; ISOGRAFT; MEMBRANE; NECROSIS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; SURVIVAL; VASCULARIZATION; XENOGRAFT;

ANIMALS; FEMALE; GRAFT REJECTION; IMMUNITY, CELLULAR; INFLAMMATION; LUNG; LUNG TRANSPLANTATION; MICE; MICE, INBRED STRAINS; NECROSIS; PREGNANCY; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0030002116     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199606270-00002     Document Type: Article

References (20)

1. Geller RL, Turman MA, Dalmasso AP, Platt JL. The natural immune barrier to xenotransplantation. J Am Soc Nephrol 1992; 3: 1189.
2. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
3. Moses RD, Pierson RN, Winn HJ, Auchincloss H Jr. Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567.
4. Colton CK, Avgoustiniatos ES. Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 1991; 113: 152.
5. Scharp DW, Mason NS, Sparks RE. Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 1995; 8: 221.
6. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991; 254: 1782.
7. Lanza RP, Butler DH, Borland KM, et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci (USA) 1991; 88: 11100.
8. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995; 4: 415.
9. Algire GH, Weaver JM, Prehn RT. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J Natl Cancer Inst 1954; 15: 493.
10. Weaver JM, Algire GH, Prehn RT. The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J Natl Cancer Inst 1955; 15: 1737.
11. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mat Res 1995; 29: 1517.
12. Carr-Brendel VE, Geller RL, Thomas TJ, et al. Transplantation of cells in an immunoisolation device for gene therapy. In: Tuan R, ed. Methods in molecular biology: expression and detection of recombinant genes. Totowa, NJ: Humana, 1995: in press.
13. Andrews EJ. The survival and differentiation of embryonic lung tissues in diffusion chambers and in mammary fat pads of mice. Anat Rec 1995; 172: 89.
14. Martinson L, Pauley R, Brauker J, et al. Protection of xenografts with immunoisolation membranes. Cell Transplant 1995; 3: 249.
15. Auchincloss H Jr. Xenogeneic transplantation. Transplantation 1988; 46: 1.
16. Ryan US. Complement inhibition: the sine qua non of Xenotransplantation. Xeno 1994; 2: 19.
17. Dorling A, Lechler RI. Prospects for xenografting. Curr Opin Immunol 1994; 6: 765.
18. Loudovaris T, Mandel TE, Charlton B. CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. Transplantation 1996; 61:?
19. Whartenby KA, Abboud CN, Marrogi AJ, Rajagopal R, Freeman SM. The biology of cancer gene therapy. Lab Invest 1995; 72: 131.
20. Sun AM. Microencapsulation of pancreatic islet cells: a bioartificial endocrine pancreas. Methods Enzymol 1988; 137: 575.